Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins.
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins. Cells. 2021 07 02; 10(7).
View in:
PubMed
subject areas
Antineoplastic Agents
Antineoplastic Combined Chemotherapy Protocols
Apoptosis
bcl-X Protein
Breast Neoplasms
Cell Line, Tumor
Drug Resistance, Neoplasm
Drug Synergism
Estrogen Receptor alpha
Female
Gene Expression Regulation, Neoplastic
Humans
Piperazines
Protein Isoforms
Proto-Oncogene Proteins c-akt
Pyridines
Pyrimidines
Signal Transduction
Sulfonamides
Thiazoles
Thiophenes
authors with profiles
Nikhil Wagle, M.D.
Anthony George Letai, M.D., Ph.D.
Jorge Gomez Tejeda Zanudo, Ph.D.